Description
CJC-1295 (without DAC) is a tetrasubstituted peptide derivative of growth hormone–releasing hormone (GHRH). The modification termed “without DAC” results in a reduced half-life, facilitating the investigation of pulsatile GH release models.
Ipamorelin is a targeted agonist of the ghrelin receptor that has been investigated for its capacity to induce GH release in vitro, while having minimal impact on prolactin or cortisol pathways.
There are no reviews yet.